CLOVER BIO-Bに関するコメント

$Hang Seng Index(800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN-B(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $維亜生物科技(01873.HK)$ ...

In FT's story, The commerce department is expected to place more than two dozen Chinese companies on the entity list on Thursday, including some involved in biotechnology.
The news triggers the sell-off in Hong Kong.
$薬明生物(02269.HK)$$無錫薬明康徳(02359.HK)$$CLOVER BIO-B(02197.HK)$$REMEGEN-B(09995.HK)$

$ダイナバクス・テクノロジーズ(DVAX.US)$ is the adjuvant for $ヴァルネヴァ(VALN.US)$ and $CLOVER BIO-B(02197.HK)$ vaccine…. they will be real answers to the new variant. Bullish